SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
08-Apr-24 4:08 PM View: | Ngm Biopharmaceuticals Inc (NGM) | 05-Apr-24 | Disposition (change in control) | 19,349 | -- | -- | (100%) 19.35K to 0 | |
18-Jan-24 6:03 PM View: | Ngm Biopharmaceuticals Inc (NGM) | 16-Jan-24 | Payment of Exercise | 5,430 | $1.34 | $7,276.20 | (9%) 59.68K to 54.25K | |
06-Mar-23 5:08 PM View: | Ngm Biopharmaceuticals Inc (NGM) | 02-Mar-23 | Grant | 53,000 | -- | -- | 2035% 2.6K to 55.6K | |
07-Oct-21 8:04 PM View: | Ngm Biopharmaceuticals Inc (NGM) | 05-Oct-21 | Option Exercise | 2,000 | $12.06 | $24,120.00 | 100% 0 to 2.0K | |
07-Oct-21 8:04 PM View: | Ngm Biopharmaceuticals Inc (NGM) | 05-Oct-21 | Market Option Sale (Planned) | 2,000 | $22.00 | $44,000.00 | (100%) 2.0K to 0 | |
13-Aug-21 4:27 PM View: | Ngm Biopharmaceuticals Inc (NGM) | 12-Aug-21 | Option Exercise | 8,000 | $12.06 | $96,480.00 | 100% 0 to 8.0K | |
13-Aug-21 4:27 PM View: | Ngm Biopharmaceuticals Inc (NGM) | 12-Aug-21 | Market Option Sale | 5,742 | $23.50 | $134,937.00 | (72%) 8.0K to 2.26K | |
13-Aug-21 4:27 PM View: | Ngm Biopharmaceuticals Inc (NGM) | 12-Aug-21 | Market Sale | 2,258 | $23.50 | $53,063.00 | (100%) 2.26K to 0 | |
13-Aug-21 4:27 PM View: | Ngm Biopharmaceuticals Inc (NGM) | 11-Aug-21 | Market Option Sale | 2,258 | $23.00 | $51,934.00 | (100%) 2.26K to 0 | |
18-May-20 4:35 PM View: | Ngm Biopharmaceuticals Inc (NGM) | 15-May-20 | Market Sale | 1,562 | $22.00 | $34,364.00 | (90%) 1.74K to 0.18K | (42%) |
02-Apr-12 3:28 PM View: | Nile Therapeutics, Inc (CAPR) | 30-Mar-12 | Purchase | 12,500 | -- | -- | 12500% 100 to 12.6K | |
20-Jul-09 4:35 PM View: | Nile Therapeutics, Inc (CAPR) | 15-Apr-08 | Market Purchase | 100 | $4.60 | $460.00 | 100% 0 to 100 | (100%) |